Clinical Trial Update: Efficacy and Safety of Empagliflozin in NODAT [Phase 4]

View source ↗

Summary

Phase 4 trial update on empagliflozin for New Onset Diabetes After Transplant (NODAT) and related kidney transplant complications; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Complications
• New Onset Diabetes After Transplant

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: RenJi Hospital | Conditions: New Onset Diabetes After Transplant, Kidney Transplant; Complications | Phase 4 | Status: TERMINATED